Page 68 - JCTR-9-6

432 Malakar et al. | Journal of Clinical and Translational Research 2023; 9(6): 423-432
et al. A Childhood Acute Lymphoblastic Leukemia-specific Implication of LncRNA MALAT1 in Promoting Chemo-
lncRNA Implicated in Prednisolone Resistance, Cell resistance of Laryngeal Squamous Cell Carcinoma Cells.
Proliferation, and Migration. Oncotarget 2017;8:7477-88. J Clin Lab Anal 2020;34:e23116.
[64] Pouyanrad S, Rahgozar S, Ghodousi ES. Dysregulation [70] Shi C, Ren S, Zhao X, Li Q. lncRNA MALAT1 Regulates
of miR-335-3p, Targeted by NEAT1 and MALAT1 Long the Resistance of Breast Cancer Cells to Paclitaxel
Non-coding RNAs, is Associated with Poor Prognosis via the miR-497-5p/SHOC2 Axis. Pharmacogenomics
in Childhood Acute Lymphoblastic Leukemia. Gene 2022;23:973-85.
2019;692:35-43. [71] Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ,
[65] Chen W, Zhao W, Zhang L, Wang L, Wang J, Wan Z, et al. Kenzelmann-Broz D, et al. A Large Intergenic Noncoding
MALAT1-miR-101-SOX9 Feedback Loop Modulates the RNA Induced by p53 Mediates Global Gene Repression in
Chemo-resistance of Lung Cancer Cell to DDP via Wnt the p53 Response. Cell 2010;142:409-19.
Signaling Pathway. Oncotarget 2017;8:94317-29. [72] Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y,
[66] Chen W, Tan X, Yang Q, Fang Z, Xu Y. MALAT1 Enhances Grant GD, et al. Extensive and Coordinated Transcription
Gemcitabine Resistance in Non-small Cell Lung Cancer of Noncoding RNAs within Cell-cycle Promoters. Nat
Cells by Directly Affecting miR-27a-5p/PBOV1 Axis. Cell Genet 2011;43:621-9.
Signal 2022;94:110326. [73] Schmitt AM, Garcia JT, Hung T, Flynn RA, Shen Y, Qu K,
[67] Feng C, Zhao Y, Li Y, Zhang T, Ma Y, Liu Y. LncRNA et al. An Inducible Long Noncoding RNA Amplifies DNA
MALAT1 Promotes Lung Cancer Proliferation and Damage Signaling. Nat Genet 2016;48:1370-6.
Gefitinib Resistance by Acting as a miR-200a Sponge. [74] Li XL, Subramanian M, Jones MF, Chaudhary R, Singh DK,
Arch Bronconeumol (Engl Ed) 2019;55:627-33. Zong X, et al. Long Noncoding RNA PURPL Suppresses
[68] Fang Z, Chen W, Yuan Z, Liu X, Jiang H. LncRNA- Basal p53 Levels and Promotes Tumorigenicity in
MALAT1 Contributes to the Cisplatin-resistance of Lung Colorectal Cancer. Cell Rep 2017;20:2408-23.
Cancer by Upregulating MRP1 and MDR1 via STAT3 [75] Casella G, Munk R, Kim KM, Piao Y, De S, Abdelmohsen K,
Activation. Biomed Pharmacother 2018;101:536-42. et al. Transcriptome Signature of Cellular Senescence.
[69] Jiang Q, Liu S, Hou L, Guan Y, Yang S, Luo Z. The Nucleic Acids Res 2019;47:7294-305.

Publisher’s note
AccScience Publishing remains neutral with regard to jurisdictional
claims in published maps and institutional affiliations.
DOI: http://dx.doi.org/10.18053/jctres.09.202306.23-00088